SEARCH

SEARCH BY CITATION

References

  • Amidon, G.L., Lennernäs, H., Shah, V.P. & Crison, J.R. (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research, 12, 413420.
  • Bailer, A.J. (1988) Testing for equality of area under the curves when using destructive measurement techniques. Journal of Pharmacokinetics and Biopharmaceutics, 16, 303309.
  • Benfeldt, E., Hansen, S.H., Vølund, A., Menné, T. & Shah, V.P. (2007) Bioequivalence of topical formulations in humans: evaluation by dermal microdialysis sampling and the dermatopharmacokinetic method. Journal of Investigative Dermatology, 127, 170178.
  • Boddy, A.W., Snikeris, F.C., Kringle, R.O., Wei, G.C., Oppermann, J.A. & Midha, K.K. (1995) An approach for widening the bioequivalence acceptance limits in the case of highly variable drugs. Pharmaceutical Research, 12, 18651868.
  • Bois, F.Y., Tozer, T.N., Hauck, W.W., Chen, M.L., Patnaik, R. & Williams, R.L. (1994) Bioequivalence: performance of several measures of rate of absorption. Pharmaceutical Research, 11, 966974.
  • Bonate, P.L. (1998) Coverage and precision of confidence intervals for area under the curve using parametric and non-parametric methods in a toxicokinetic experimental design. Pharmaceutical Research, 15, 405410.
  • Boulton, D.W. & Fawcett, J.P. (2001) The pharmacokinetics of levosalbutamol: what are the clinical implications? Clinical Pharmacokinetics, 40, 2340.
  • Brocks, D.R. (2006) Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics. Biopharmaceutics & Drug Disposition, 27, 387406.
  • Brocks, D.R., Ramaswamy, M., MacInnes, A.I. & Wasan, K.M. (2000) The stereoselective distribution of halofantrine enantiomers within human, dog, and rat plasma lipoproteins. Pharmaceutical Research, 17, 427431.
  • Burton, P.S., Goodwin, J.T., Vidmar, T.J. & Amore, B.M. (2002) Predicting drug absorption: how nature made it a difficult problem. Journal of Pharmacology and Experimental Therapeutics, 303, 889895.
  • Cabana, B.E. (1983) Assessment of 75/75 rule: FDA viewpoint. Journal of Pharmaceutical Sciences, 72, 98100.
  • Capece, B.P.S., Virkel, G.L. & Lanusse, C.E. (2009) Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: pharmacological implications. The Veterinary Journal, 181, 241250.
  • Del Castillo, J.R.E. & Wolff, T. (2006) Therapeutic lung exposure to feed-administered chlortetracycline is premix brand dependent. American Association of Swine Veterinarians Proceedings, 143148.
  • CDER (2003) CDER Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products – General Considerations. March. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070124.pdf [accessed on 14 August 2009].
  • Chakrabarty, A.N., Dastidar, S.G., Ganguli, M. & Chattopadhyay, D. (1990) ‘DNA’ as contaminants in antibiotics and its capacity to transform bacteria to drug resistance. Indian Journal of Experimental Biology, 28, 5862.
  • Charter, M.K. & Gull, S.F. (1987) Maximum entropy and its application to the calculation of drug absorption rates. Journal of Pharmacokinetics and Biopharmaceutics, 15, 645655.
  • Chen, M.L. (1992) An alternative approach for assessment of rate of absorption in bioequivalence studies. Pharmaceutical Research, 9, 13801385.
  • Chen, M.L., Lesko, L. & Williams, R.L. (2001) Measures of exposure versus measures of rate and extent of absorption. Clinical Pharmacokinetics, 40, 565572.
  • 21 Code of Federal Regulations (1977) Basis for Demonstrating In-Vivo Bioavailability or Bioequivalence Requirements. §320.23.
  • Dahan, A., Miller, J.M. & Amidon, G.L. (2009) Prediction of Solubility and Permeability Class Membership: provisional BCS Classification of the World’s Top Oral Drugs. AAPS Journal, 11, 740746.
  • Ehinger, A.M. & Kietzmann, M. (2000a) Tissue distribution of benzylpenicillin after intramammary administration in the isolated perfused bovine udder. Journal of Veterinary Pharmacology and Therapeutics, 23, 303310.
  • Ehinger, A.M. & Kietzmann, M. (2000b) Tissue distribution of oxacillin and ampicillin in the isolated perfused bovine udder. Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine, 47, 157168.
  • Eisemann, J.H., Huntington, G.B. & Catherman, D.R. (1996) Patterns of nutrient exchange and oxygen use among portal drained viscera, liver and hindquarters of beef steers from 235 to 525 kg body weight. Journal of Animal Science, 74, 18121831.
  • Endrenyi, L. & Tothfalusi, L. (1997) Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives. International Journal of Clinical Pharmacology and Therapeutics, 35, 142150.
  • Endrenyi, L., Fritsch, S. & Yan, W. (1991) Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence. International Journal of Clinical Pharmacology, Therapy and Toxicology, 29, 394399.
  • Endrenyi, L., Csizmadia, F., Tothfalusi, L., Balch, A.H. & Chen, M.L. (1998) The duration of measuring partial AUCs for the assessment of bioequivalence. Pharmaceutical Research, 15, 399404.
  • Fahmy, R., Danielson, D. & Martinez, M. (2008) Formulation and Design of Veterinary Tablets. In Pharmaceutical Dosage Forms: Tablets, Chapter 13. Informa Healthcare, 3, 383431.
  • Federal Register (1977) Drug Products, Bioequivalence Requirements and in vivo Bioavailability Procedures. Federal Register, 42, 16341635.
  • Fernández-Teruel, C., Nalda Molina, R., González-Alvarez, I., Navarro-Fontestad, C., García-Arieta, A., Casabó, V.G. & Bermejo, M. (2009) Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I). European Journal of Pharmaceutical Sciences, 36, 137146.
  • Gehring, T. & Smith, G.W. (2006) An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis. Journal of Veterinary Pharmacology and Therapeutics, 29, 237241.
  • Giantin, M., Carletti, M., Capolongo, F., Pegolo, S., Lopparelli, R.M., Gusson, F., Nebbia, C., Cantiello, M., Martin, P., Pineau, T. & Dacasto, M. (2008) Effect of breed upon cytochromes P450 and phase II enzyme expression in cattle liver. Drug Metabolism and Disposition, 36, 885893.
  • Granero, G.E. & Amidon, G.L. (2008) Possibility of enterohepatic recycling of ketoprofen in dogs. International Journal of Pharmaceutics, 12, 166171.
  • Haidar, S.H., Makhlouf, F., Schuirmann, D.J., Hyslop, T., Davit, B., Conner, D. & Yu, L.X. (2008) Evaluation of a scaling approach for the bioequivalence of highly variable drugs. AAPS Journal, 10, 450454.
  • Hamrell, M.R., Martinez, M.N., Dighe, S.V. & Parkman, P.D. (1987) Bioequivalence of generic thioridazine drug products – the FDA viewpoint. Drug Intelligence & Clinical Pharmacy, 21, 362372.
  • Hauck, W.W. & Anderson, S. (1984) A new statistical procedure for testing equivalence in two-group comparative bioavailability trials. Journal of Pharmacokinetics and Biopharmaceutics, 12, 8391.
  • Hauschke, D., Kieser, M., Diletti, E. & Burke, M. (1999) Sample size determination for proving equivalence based on the ratio of two means for normally distributed data. Statistics in Medicine, 18, 93105.
  • Henricks, D.M., Edwards, R.L., Champe, K.A., Gettys, T.W., Skelly, G.C. & Gimenez, T. (1982) Trenbolone, estradiol-17 beta and estrone levels in plasma and tissues and live weight gains of heifers implanted with trenbolone acetate. Journal of Animal Science, 55, 10481056.
  • Higaki, K., Choe, S.Y., Löbenberg, R., Welage, L.S. & Amidon, G.L. (2008) Mechanistic understanding of time-dependent oral absorption based on gastric motor activity in humans. European Journal of Pharmaceutics and Biopharmaceutics, 70, 313325.
  • Hunter, R.P. (2009) Zoological pharmacology. In Veterinary Pharmacology and Therapeutics, 9th edn. Eds Riviere, J.E. & Papich, M.G., pp. 13431352. Iowa State University Press, Ames, IA.
  • Igarza, L., Soraci, A., Auza, N. & Zeballos, H. (2004) Some pharmacokinetic parameters of R-(-)- and S-(+)-ketoprofen: the influence of age and differing physiological status in dairy cattle. Veterinary Research Communications, 28, 8187.
  • Jackson, A.J. & Chen, M.-L. (1987) Application of moment analysis in assessing rates of absorption for bioequivalency studies. Journal of Pharmaceutical Sciences, 76, 69.
  • Jackson, A.J., Robbie, G. & Marroum, P. (2004) Metabolites and bioequivalence: past and present. Clinical Pharmacokinetics, 43, 655672.
  • Jaki, T., Wolfsegger, M.J. & Ploner, M. (2009) Confidence intervals for ratios of AUCs in the case of serial sampling: a comparison of seven methods. Pharmaceutical Statistics, 8, 1224.
  • Jones, B. & Kenward, M.G. (1989) Design and Analysis of Cross-Over Trials. Chapman and Hall, New York.
  • Landoni, M.F. & Lees, P. (1996) Chirality: a major issue in veterinary pharmacology. Journal of Veterinary Pharmacology and Therapeutics, 19, 8284.
  • Lennernas, H. (1995) Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation? Pharmaceutical Research, 12, 15731582.
  • Li, J., Petit-Jetté, C.E., Gohore Bi, D., Fenneteau, F., Del Castillo, J.R. & Nekka, F. (2008) Assessing pharmacokinetic variability directly induced by drug intake behaviour through development of a feeding behaviour-pharmacokinetic model. Journal of Theoretical Biology, 251, 468479.
  • Lipka, E., Lee, I.D., Langguth, P., Spahn-Langguth, H., Mutschler, E. & Amidon, G.L. (1995) Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs. Journal of Pharmacokinetics and Biopharmaceutics, 23, 267286.
  • Lovering, E.G., McGilveray, I.J., McMillan, I. & Tostowaryk, W. (1975) Comparative bioavailabilities from truncated blood level curves. Journal of Pharmaceutical Sciences, 64, 15211524.
  • Martinez, M.N. & Amidon, G.L. (2002) A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. Journal of Clinical Pharmacology, 42, 620643.
  • Martinez, M.N. & Jackson, A.J. (1991) Suitability of various noninfinity area under the plasma concentration–time curve (AUC) estimates for use in bioequivalence determinations: relationship to AUC from zero to time infinity (AUC0-INF). Pharmaceutical Research, 8, 512517.
  • Martinez, M.N. & Riviere, J.E. (1994) Review of the 1993 Veterinary Drug Bioequivalence Workshop. Journal of Veterinary Pharmacology and Therapeutics, 17, 85119.
  • Martinez, M.N., Pedersoli, W.M., Ravis, W.R., Jackson, J.D. & Cullison, R. (2001) Feasibility of interspecies extrapolation in determining the bioequivalence of animal products intended for intramuscular administration. Journal of Veterinary Pharmacology and Therapeutics, 24, 125135.
  • Martinez, M., Amidon, G., Clarke, L., Jones, W.W., Mitra, A. & Riviere, J. (2002) Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II. Physiological considerations. Advanced Drug Delivery Reviews, 54, 825850.
  • Martinez, M.N., Papich, M.G. & Riviere, J.E. (2004) Veterinary application of in vitro dissolution data and the biopharmaceutics classification system. US Pharmacopeial Forum, 30, Nov–Dec.
  • Martinez, M., Rathbone, M., Burgess, D. & Huynh, M. (2008) In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting. Journal of Controlled Release, 129, 7987.
  • Martinez, M.N., Rathbone, M.J., Burgess, D. & Huynh, M. (2010) Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products. Journal of Controlled Release, 132, 27.
  • Marzo, A. & Reiner, V. (2004) Open questions on bioequivalence: the case of multiple peak phenomenon. The Journal of Pharmacy and Pharmacology, 56, 281282.
  • Mauger, D.T. & Chinchilli, V.M. (2000) An alternative index for assessing profile similarity in bioequivalence trials. Statistics in Medicine, 19, 28552866.
  • Mehvar, R. & Jamali, F. (1997) Bioequivalence of chiral drugs. Stereospecific versus non-stereospecific methods. Clinical Pharmacokinetics, 33, 122141.
  • Mehvar, R., Brocks, D.R. & Vakily, M. (2002) Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs. Clinical Pharmacokinetics, 41, 533558.
  • Midha, K.K., Hubbard, J.W., Rawson, M. & Gavalas, L. (1994) The application of partial areas in assessment of rate and extent of absorption in bioequivalence studies of conventional release products: experimental evidence. European Journal of Pharmaceutical Sciences, 2, 351363.
  • Midha, K.K., McKay, G., Rawson, M.J. & Hubbard, J.W. (1998a) The impact of stereoisomerism in bioequivalence studies. Journal of Pharmaceutical Sciences, 87, 797802.
  • Midha, K.K., Rawson, M.J. & Hubbard, J.W. (1998b) Bioequivalence: switchability and scaling. European Journal of Pharmaceutical Sciences, 6, 8791.
  • Midha, K.K., Rawson, M.J. & Hubbard, J.W. (2004) The role of metabolites in bioequivalence. Pharmaceutical Research, 21, 13311344.
  • Mossinghoff, G.J. (1999) Overview of the Hatch-Waxman Act and its impact on the drug development process. Food and Drug Law Journal, 54, 187194.
  • National Research Council (2000) Nutrient Requirements of Beef Cattle: Seventh Revised Edition: Update 2000. National Academy Press, Washington, DC.
  • National Research Council (2001) Nutrient Requirements of Dairy Cattle: Seventh Revised Edition, 2001. National Academy Press, Washington, DC.
  • N’Dri-Stempfer, B., Navidi, W.C., Guy, R.H. & Bunge, A.L. (2009) Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics. Pharmaceutical Research, 26, 316328.
  • Nedelman, J.R., Gibiansky, E. & Lau, D.T. (1995) Applying Bailer’s method for AUC confidence intervals to sparse sampling. Pharmaceutical Research, 12, 124128.
  • Nerurkar, J., Beach, J.W., Park, M.O. & Jun, H.W. (2005) Solubility of (±)-ibuprofen and S(+)-ibuprofen in the presence of cosolvents and cyclodextrins. Pharmaceutical Development and Technology, 10, 413421.
  • Niazi, S.K., Alam, S.M. & Ahmad, S.I. (1997) Partial-area method in bioequivalence assessment: naproxen. Biopharmaceutics and Drug Disposition, 18, 103116.
  • Pusateri, A.E. & Kenison, D.C. (1993) Measurement of zeranol in plasma from three blood vessels in steers implanted with zeranol. Journal of Animal Science, 71, 415429.
  • Rescigno, A. (1992) Bioequivalence. Pharmaceutical Research, 9, 925928.
  • Reynolds, C.K., Aikman, P.C., Lupoli, B., Humphries, D.J. & Beever, D.E. (2003) Splanchnic metabolism of dairy cows during the transition period from late gestation through early lactation. Journal of Dairy Science, 86, 12011217.
  • Roberts, M.S., Magnusson, B.M., Burczynski, F.J. & Weis, M. (2002) Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clinical Pharmacokinetics, 4, 751790.
  • Roger, S.D. & Mikhail, A. (2007) Biosimilars: opportunity or cause for concern? Journal of Pharmacy & Pharmaceutical Sciences, 10, 405410.
  • Ronfeld, R.A. & Benet, L.Z. (1977) Interpretation of plasma concentration–time curves after oral dosing. Journal of Pharmaceutical Sciences, 66, 178180.
  • Rule, R., Quiroga, G.H., Rubio, M., Buschiazzo, H.O. & Buschiazzo, P.M. (1996) The pharmacokinetics of ceftazidime in lactating and non-lactating cows. Veterinary Research Communications, 20, 543550.
  • Russek-Cohen, E., Martinez, M. & Nevius, A. (1999) A Nonparametric Approach to Bioequivalence in a Repeated Measures Design. Proceedings of the American Statistical Association.
  • Sagara, K., Mizuta, H., Ohshiko, M., Shibata, M. & Haga, K. (1995) Relationship between the phasic period of interdigestive migrating contraction and the systemic bioavailability of acetaminophen in dogs. Pharmaceutical Research, 12, 594598.
  • Sallovitz, J., Lifschitz, A., Imperiale, F., Pis, A., Virkel, G. & Lanusse, C. (2002) Breed differences on the plasma availability of moxidectin administered pour-on to calves. The Veterinary Journal, 164, 4753.
  • Schadewinkel-Scherkl, A.M., Rasmussen, F., Merck, C.C., Nielsen, P. & Frey, H.H. (1993) Active transport of benzylpenicillin across the blood-milk barrier. Pharmacology and Toxicology, 73, 1419.
  • Schuirmann, D.J. (1987) A comparison of the two-one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics, 15, 657680.
  • Short, C.R. (1994) Consideration of sheep as a minor species: comparison of drug metabolism and disposition with other domestic ruminants. Veterinary and Human Toxicology, 36, 2440.
  • Schellekens, H. (2009) Assessing the bioequivalence of Biosimilars: the Retacit® case. Drug Discovery Today, 14, 495499.
  • Soback, S., Ziv, G., Winkler, M. & Saran, A. (1990) Systemic dry cow therapy – a preliminary report. Journal of Dairy Science, 73, 661666.
  • Srichana, T. & Suedee, R. (2001) Evaluation of stereoselective dissolution of racemic salbutamol matrices prepared with commonly used excipients and H-NMR study. Drug Development and Industrial Pharmacy, 27, 457464.
  • Sumano, L.H., Ocamp, C.L. & Gutiérrez, O.L. (2001) Non-bioequivalence of various trademarks of enrofloxacin and Baytril® in cows. Deutsche tierärztliche Wochenschrift, 108, 311314.
  • Takemoto, S., Yamaoka, K., Nishikawa, M. & Takakura, Y. (2006) Histogram analysis of pharmacokinetic parameters by bootstrap resampling from one-point sampling data in animal experiments. Drug Metabolism and Pharmacokinetics, 21, 458464.
  • Testa, B. (2009) Prodrugs: bridging pharmacodynamic/pharmacokinetic gaps. Current Opinion in Chemical Biology, 13, 338344.
  • Tothfalusi, L., Endrenyi, L., Midha, K.K., Rawson, M.J. & Hubbard, J.W. (2001) Evaluation of the bioequivalence of highly-variable drugs and drug products. Pharmaceutical Research, 18, 728733.
  • Toutain, P.L. & Bousquet-Melou, A. (2004) Bioavailability and its assessment. Journal of Veterinary Pharmacology and Therapeutics, 27, 455466.
  • Toutain, P.L. & Koritz, G.D. (1997) Veterinary drug bioequivalence determination. Journal of Veterinary Pharmacology and Therapeutics, 20, 7990.
  • Tozer, T.N., Bois, F.Y., Hauck, W.W., Chen, M.L. & Williams, R.L. (1996) Absorption rate vs. exposure: which is more useful for bioequivalence testing? Pharmaceutical Research, 13, 453456.
  • Veldhuyzen van Zanten, S.J., Pollak, P.T., Kapoor, H. & Yeung, P.K. (1996) Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment of Helicobacter pylori. Digestive Disease Sciences, 41, 18451852.
  • Veng-Pedersen, P. & Tillman, L.G. (1989) Center of gravity of drug level curves: a model-independent parameter useful in bioavailability studies. Journal of Pharmaceutical Sciences, 78, 848854.
  • Wang, Y., Roy, A., Sun, L. & Lau, C.E. (1999) A double-peak phenomenon in the pharmacokinetics of alprazolam after oral administration. Drug Metabolism and Disposition, 27, 855859.
  • Webb, V. & Davies, J. (1993) Antibiotic preparations contain DNA: a source of drug resistance genes? Antimicrobial Agents and Chemotherapy, 37, 23792384.
  • Wolfsegger, M.J. (2007) Establishing bioequivalence in serial sacrifice designs. Journal of Pharmacokinetics and Pharmacodynamics, 34, 103113.
  • Yu, L.X., Amidon, G.L., Polli, J.E., Zhao, H., Mehta, M.U., Conner, D.P., Shah, V.P., Lesko, L.J., Chen, M.L., Lee, V.H. & Hussain, A.S. (2002) Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharmaceutical Research, 19, 921925.
  • Ziv, G. (1980) Practical pharmacokinetic aspects of mastitis therapy. Veterinary Medicine, Small Animal Clinician, 75, 657670.